http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-200800285-A1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65583
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-351
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-381
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12
filingDate 2006-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2008-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EA-200800285-A1
titleOfInvention NEW DERIVATIVES 2,4-DIANILINOPIRIMIDINES, THEIR PRODUCTION, MEDICINES, PHARMACEUTICAL COMPOSITIONS, CONTAINING INDICATED DERIVATIVES, AND THEIR APPLICATION, IN PARTICULAR, AS THE PROTECTIVE.
abstract The invention relates to products of formula (I) in which R2, R3 and R4 denote one halogen atom and the others denote hydrogen, halogen, alkyl or alkoxy; R5 is hydrogen or halogen; R1 is hydrogen, cycloalkyl, alkyl, alkenyl or alkynyl, all optionally substituted; A is a single bond or a radical β€”CH β€” CO β€” NR6β€”, where R6 is selected from the values of R1; moreover, the cycle containing Y (or cycle (Y)) consists of 4-8 links and Y denotes O, S, SO, SO, N-R7 (and cycle (Y) may include a carbon bridge), C = O or dioxolane, CF, CH-OR8, CH-NR8R9; R7 is hydrogen, cycloalkyl, alkyl, CH-alkenyl or CH-alkynyl optionally substituted; R8 is hydrogen, alkyl, cycloalkyl or heterocycloalkyl optionally substituted, which products are in all possible isomeric forms, as well as their salts, as medicaments, in particular as IKK inhibitors.
priorityDate 2005-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID138198
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415838535
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451

Total number of triples: 35.